Figure 4

The percentage of IL-4-synthesizing T cell subsets (A) and the MFI of IL-4-positive T cell subsets (B) treated for 24 and 48 h with 30, 300 and 3000 ng/ml of aglepristone. All data are presented relative to control values (line). Each point represents an individual dog (N = 7–8), with the bar indicating the mean. *P < 0.05, ** P < 0.01.